INVITROCUE

In News

3 companies fined nearly $1.2m in total for financial reporting breaches - Accounting Times

Accounting Times - Apr 01, 2026

Singapore approves Invitrocue's Onco-PDO test as personalised oncology service - BioSpectrum Asia

BioSpectrum Asia - Mar 05, 2024

Singapore entrepreneur sold family home twice to fund startups, and gave up S$750,000 annual salary - Yahoo Finance Singapore

Yahoo Finance Singapore - Mar 03, 2024

The Resilient Journey of Invitrocue – Pioneering Biotech Solutions and Transforming Lives - SME & Entrepreneurship Magazine

SME & Entrepreneurship Magazine - Feb 15, 2024

Biotech firm offers personalized cancer drug test to Hong Kong - The Standard (HK)

The Standard (HK) - Jun 28, 2021

Invitrocue and Genome Institute of Singapore to develop in vitro cancer models - Proactive financial news

Proactive financial news - Jul 20, 2017

International MoU between Hong Kong, Singapore, and Europe Biomedical Talents | HKSTP - Hong Kong Science & Technology Parks Corporation

Hong Kong Science & Technology Parks Corporation - May 17, 2022

Invitrocue creates Joint Venture with A*STAR scientist Dr Chen Qingfeng - BioSpectrum Asia

BioSpectrum Asia - Feb 12, 2019

Invitrocue Limited (ASX: IVQ) - Share Price - intelligentinvestor.com.au

intelligentinvestor.com.au - Feb 05, 2020

Me & My Money: Entrepreneur sells his home to fund biotech start-up - The Straits Times

The Straits Times - Apr 21, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment